Croda International Plc (LON:CRDA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is GBX 3,140.
A number of equities research analysts have issued reports on the stock. Morgan Stanley upgraded shares of Croda International to an "overweight" rating and increased their target price for the stock from GBX 3,280 to GBX 3,350 in a research report on Wednesday, March 25th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Croda International from GBX 3,100 to GBX 3,000 and set a "hold" rating for the company in a research report on Tuesday, March 24th.
View Our Latest Research Report on Croda International
Croda International Stock Up 2.4%
CRDA stock opened at GBX 3,051 on Friday. Croda International has a 12-month low of GBX 2,426.77 and a 12-month high of GBX 3,312. The company has a quick ratio of 2.25, a current ratio of 1.99 and a debt-to-equity ratio of 31.85. The company has a market cap of £4.25 billion, a price-to-earnings ratio of 68.72, a PEG ratio of 1.40 and a beta of 0.94. The company has a 50 day moving average of GBX 2,893.71 and a two-hundred day moving average of GBX 2,815.51.
Croda International (LON:CRDA - Get Free Report) last released its earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 3.65% and a return on equity of 2.82%. On average, equities analysts anticipate that Croda International will post 181.8307268 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Croda International news, insider Tom Brophy sold 1,020 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of GBX 2,652, for a total value of £27,050.40. Also, insider Steve Foots sold 3,622 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of GBX 2,606, for a total transaction of £94,389.32. Insiders purchased a total of 771 shares of company stock worth $2,152,788 in the last quarter. 0.83% of the stock is currently owned by corporate insiders.
About Croda International
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.